Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies
Introduction
Biofilms are structured aggregations of microorganisms associated with surfaces that have been widely studied over the past few decades in part because they cause 65% or more of all infections, being particularly prevalent in device-related infections, infections on body surfaces (skin and soft tissue, lung, bladder, endocarditis, etc.) and chronic infections [1, 2, 3]. They are particularly problematic due to their resistance to host defence mechanisms and to conventional antimicrobial therapy, which substantially hinders their treatment in the clinic [1, 2, 3, 4]. From a broader perspective, biofilms are ancient phenotypic adaptations to the environment and are ubiquitous in Nature [1].
In this review, we will summarize the most recent advances in the field of biofilm research and analyze these findings from the perspective that biofilms have developed as a survival strategy of adaptation to environmental stress. In this context, we explain the most recent findings about the adaptive antibiotic resistance mechanisms displayed by biofilms, as well as the new therapeutic strategies aimed at effectively inhibiting and/or eradicating biofilms.
Section snippets
Biofilm formation: an adaptive response to hostile environments
Biofilms appear early in the fossil record (∼3.25 billion years ago), and are common in a broad range of organisms, including not only bacteria but also archaea and eukaryotic microbes such as fungi [1]. The emergence of these primitive biofilms appears to have coincided with the first evidence of an evolutionary transition from unicellular to multicellular organization, which was provided by fossils of prokaryotic filamentous and mat-forming cyanobacteria-like organisms [1]. This suggests that
Biofilm formation in Nature and in the clinic
Biofilms are formed in diverse environmental niches, including hydrothermal hot springs and deep-sea vents, freshwater rivers, rocks, etc. [1, 2]. Additionally, these multicellular structures have been observed in various industrial and clinical settings [1, 2, 11, 12, 13•]. This suggests that the presence of stress signals in most natural and human ecosystems drives bacteria to exist predominantly within the protective milieu of a biofilm structure. Cells within biofilms have been shown to be
Mechanisms of antibiotic resistance in biofilms
While many explanations have been advanced to explain the high antibiotic resistance displayed by bacterial biofilms, it constitutes a clear example of adaptive resistance, a phenomenon that is increasingly attracting the attention of clinical microbiologists [17]. The adaptive nature of biofilm resistance is evidenced by the fact that cells taken from a biofilm and brought back to the planktonic state generally recover their original susceptibility [18]. It is worth noting, however, that
New concepts in biofilm prevention and eradication
The traditional focus on discovering compounds that target the planktonic mode of growth, both in vitro and in vivo, and the insufficient level of understanding of the biofilm phenotype have resulted in a lack of available drugs that specifically target bacterial biofilms. In the clinic, biofilm infections are usually treated with combinations of antibiotics [11, 12, 13•, 14]. Conversely, in the case of device-related biofilm infections, the device often has to be removed and replaced, a
Conclusions and future directions
Throughout their evolution, bacteria have gradually adapted to endure situations of environmental stress. One such adaptation entails the formation of biofilms, multicellular specialized structures that have become very efficient at tolerating external insults. On the basis of our current knowledge about the biology of biofilms, we can speculate that the evolutionary adaptation to the biofilm mode of growth may have been driven by stress signals present in the natural environment. One
References and recommended reading
Papers of particular interest, published within the period of review, have been highlighted as:
• of special interest
•• of outstanding interest
Acknowledgements
The authors would like to apologize for the numerous studies on biofilms that could not be included here given the concise nature of this review article. This work was supported by grants from the National Institutes of Health, Canadian Institutes for Health Research, Cystic Fibrosis Canada. REWH holds a Canada Research Chair in Health and Genomics. CDLF-N received a scholarship from the Fundación ‘la Caixa’ and Fundación Canadá (Spain).
References (66)
- et al.
Finding gene-expression patterns in bacterial biofilms
Trends Microbiol
(2005) - et al.
Pseudomonas aeruginosa: all roads lead to resistance
Trends Microbiol
(2011) - et al.
Antibiotic resistance of Pseudomonas aeruginosa colonizing a urinary catheter in vitro
Eur J Clin Microbiol
(1985) - et al.
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Nat Biotechnol
(2006) - et al.
Bacterial biofilms: from the natural environment to infectious diseases
Nat Rev Microbiol
(2004) - et al.
Bacterial biofilms: a common cause of persistent infections
Science
(1999) - et al.
Biofilm formation as microbial development
Annu Rev Microbiol
(2000) Biofilms in lab and nature: a molecular geneticist's voyage to microbial ecology
Int Microbiol
(2010)- et al.
Gene expression in Pseudomonas aeruginosa biofilms
Nature
(2001) - et al.
Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development
Mol Microbiol
(1998)
The involvement of cell-to-cell signals in the development of a bacterial biofilm
Science
Extracellular DNA required for bacterial biofilm formation
Science
The biofilm matrix
Nat Rev Microbiol
Pseudomonas aeruginosa biofilms in cystic fibrosis
Future Microbiol
The clinical impact of bacterial biofilms
Int J Oral Sci
Biofilm infections, their resilience to therapy and innovative treatment strategies
J Intern Med
A review of the scientific evidence for biofilms in wounds
Wound Repair Regen
Medical biofilms
Biotechnol Bioeng
Creeping baselines and adaptive resistance to antibiotics
Drug Resist Updat
Biofilm growth alters regulation of conjugation by a bacterial pheromone
Mol Microbiol
Staphylococcus aureus biofilms promote horizontal transfer of antibiotic resistance
Antimicrob Agents Chemother
Increased mutability of Pseudomonas aeruginosa in biofilms
J Antimicrob Chemother
Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria
Science
Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin
PLoS Genet
Involvement of the lon protease in the SOS response triggered by ciprofloxacin in Pseudomonas aeruginosa PAO1
Antimicrob Agents Chemother
Involvement of an ATP-dependent protease, PA0779/AsrA, in inducing heat shock in response to tobramycin in Pseudomonas aeruginosa
Antimicrob Agents Chemother
Escherichia coli heat-shock proteins IbpA and IbpB affect biofilm formation by influencing the level of extracellular indole
Microbiology
HrcA and DnaK are important for static and continuous-flow biofilm formation and disinfectant resistance in Listeria monocytogenes
Microbiology
Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms
Antimicrob Agents Chemother
Hypoxia increases antibiotic resistance in Pseudomonas aeruginosa through altering the composition of multidrug efflux pumps
Antimicrob Agents Chemother
Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms
Antimicrob Agents Chemother
Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes
Mol Microbiol
Multidrug tolerance of biofilms and persister cells
Curr Top Microbiol Immunol
Cited by (599)
Comparative analysis of multidrug-resistant Klebsiella pneumoniae strains of food and human origin reveals overlapping populations
2024, International Journal of Food MicrobiologyOn the possibility of engineering social evolution in microfluidic environments
2024, Biophysical JournalBiosurfactant-based silver nanoparticles: Recent advances and their applications in antimicrobial drug resistance
2024, Journal of Drug Delivery Science and TechnologyBacteriophage entrapped chitosan microgel for the treatment of biofilm-mediated polybacterial infection in burn wounds
2023, International Journal of Biological Macromolecules